Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disseminated drug-resistant nocardiosis in a patient with advanced HIV.

IDCases·2026
Same author

Universal Hepatitis B Vaccination at Birth-Risks of Revising the Recommendation.

JAMA·2025
Same author

Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.

The New England journal of medicine·2025
Same author

Case 29-2025: A 43-Year-Old Woman with Depression, Suicidal Ideation, and Fever.

The New England journal of medicine·2025
Same author

Legal Liability in Neurology: Navigating Malpractice and Regulatory Compliance.

Seminars in neurology·2025
Same author

Novel applications of large language models in clinical research.

The Journal of allergy and clinical immunology·2025

Related Experiment Video

Updated: May 11, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Central nervous system vasculitis secondary to systemic sclerosis.

Michael S Abers1, Emitseilu K Iluonakhamhe, Corey E Goldsmith

  • 1Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. abers@bcm.edu

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|May 14, 2013
PubMed
Summary

Systemic sclerosis can rarely affect the central nervous system (CNS) with vasculitis. This case highlights a young patient with a severe, treatment-resistant CNS vasculitis, emphasizing the need for clinical consideration.

Keywords:
Central nervous systemSclerodermaSystemic sclerosis vasculitis

More Related Videos

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Related Experiment Videos

Last Updated: May 11, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Background:

  • Systemic sclerosis (SSc), or scleroderma, is a fibrotic autoimmune disease with varied manifestations.
  • Central nervous system (CNS) involvement is infrequent in SSc patients.
  • CNS vasculitis is an exceptionally rare complication of SSc.

Observation:

  • This report details the fourth documented case of CNS vasculitis in a patient with SSc.
  • The patient presented at age 24, markedly younger than previously reported cases (middle-aged to elderly females).
  • The patient exhibited a rapidly progressive disease course and limited response to immunosuppressive therapies.

Findings:

  • The case represents a unique presentation of SSc-associated CNS vasculitis in a young adult.
  • The aggressive clinical trajectory and therapeutic resistance observed are novel findings in this rare condition.
  • This case expands the known clinical spectrum of CNS vasculitis in SSc.

Implications:

  • Clinicians should consider CNS vasculitis in the differential diagnosis for SSc patients presenting with neurological deficits.
  • Early recognition and diagnosis are crucial for managing this rare but severe complication.
  • Further research may elucidate specific risk factors and optimal treatment strategies for SSc-related CNS vasculitis.